It is firmly established that aging is associated with chronic low-grade inflammation. Chronic inflammation has been proposed to be a primary cause of aging, to exacerbate/accelerate age-associated diseases such as Alzheimer\'s disease, to alter normal immune function and thereby increase susceptibility to infection and cancer, and to be a viable pharmacological target for delayed disease progression and enhanced longevity. Age-associated inflammation is the result of a wide range of factors that include deregulation of senescent cells, environmental exposures, and age-associated illnesses. Thus, age-associated inflammation can be considered as both cause and effect during aging at the cellular and organismal level and is inseparable from almost all aspects of biological aging.

The purpose of the 2011 conference was to provide a forum for the presentation and dissemination of recent findings pertaining to age-associated inflammation. To this end, speakers were recruited who are working on exciting new studies that help to clarify the molecular mechanisms underlying age-associated inflammation, and its causal relationship to diabetes, muscle wasting, neurodegenerative diseases, cancer, and infection and immunity, as well as a target for prophylactic intervention. Importantly, *in vivo* animal models of inflammation during aging were emphasized. Thus, an exciting conference was organized relevant to the understanding of the basis of inflammation during aging, its contribution toward development of age-related diseases, and how anti-inflammatory regimens might confer protection. Abstracts from posters presented at the meeting are presented in this special abstract issue to provide an overview of the breadth and depth of the program. A follow-up issue will publish papers submitted by invited speakers and other participants.
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Table IEffect of aging on myofiber size before and after injury.Myofiber cross-sectional area (µm^2^)[a](#TF0001){ref-type="table-fn"}MaleFemaleBaseline14D post-CTXBaseline14D post-CTXYoung2,628±52.11,632±101.62,115±68.41,624±81.5Middle2,797±62.71,523±43.62,077±60.71,423±36.9Old2,090±124.91,402±75.11,499±206.51,326±68.4[^1]
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![fluids: (A) normal rabbit SF, (B--G) saline injection, (H) injected HA, HA injection at days (I-N) 7 and (O-T) 28 after surgery.](PBA-1-14729-g001){#F0001}

![Total HA by M~r~ (A) saline injection, (B) injected HA, and after HA injection at days (C) 7 and (D) 28. Stacked bars: (top) endogenous HA and (bottom) injected. Dashed line: normal rabbit SF.](PBA-1-14729-g002){#F0002}

![Calculated time constants by M~r~ bin for Non-Op (−) and ACLT (+) data at days 7 and 28.\* *P*\<0.05; \*\* *P*\<0.01 for Non-Op versus ACLT.](PBA-1-14729-g003){#F0003}
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[^1]: ^a^Values expressed as mean±SE (*n=*5 -- 13/group).
